Shanghai Pharmaceuticals Holding Stock Buy Hold or Sell Recommendation

SHPMY Stock  USD 8.20  0.32  4.06%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Shanghai Pharmaceuticals Holding is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Shanghai Pharmaceuticals Holding given historical horizon and risk tolerance towards Shanghai Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Shanghai Pharmaceuticals Holding, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Shanghai Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Shanghai and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Shanghai Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Execute Shanghai Pharmaceuticals Buy or Sell Advice

The Shanghai recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Shanghai Pharmaceuticals Holding. Macroaxis does not own or have any residual interests in Shanghai Pharmaceuticals Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Shanghai Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Shanghai PharmaceuticalsBuy Shanghai Pharmaceuticals
Strong Sell

Market Performance

ModestDetails

Volatility

Moderately volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Shanghai Pharmaceuticals Holding has a Mean Deviation of 3.06, Semi Deviation of 3.39, Standard Deviation of 5.33, Variance of 28.45, Downside Variance of 23.2 and Semi Variance of 11.5
We provide advice to complement the current expert consensus on Shanghai Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Shanghai Pharmaceuticals is not overpriced, please validate all Shanghai Pharmaceuticals fundamentals, including its price to sales, earnings per share, five year return, as well as the relationship between the cash per share and retained earnings . Given that Shanghai Pharmaceuticals has a price to sales of 0.04 X, we advise you to double-check Shanghai Pharmaceuticals Holding market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Shanghai Pharmaceuticals Trading Alerts and Improvement Suggestions

Shanghai Pharmaceuticals had very high historical volatility over the last 90 days

Shanghai Pharmaceuticals Returns Distribution Density

The distribution of Shanghai Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Shanghai Pharmaceuticals' future price movements. The chart of the probability distribution of Shanghai Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Shanghai Pharmaceuticals Holding price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Shanghai Pharmaceuticals returns is essential to provide solid investment advice for Shanghai Pharmaceuticals.
Mean Return
0.35
Value At Risk
-6.87
Potential Upside
9.21
Standard Deviation
5.33
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Shanghai Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Shanghai Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Shanghai Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Shanghai Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Shanghai pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.29
β
Beta against Dow Jones0.47
σ
Overall volatility
5.39
Ir
Information ratio 0.04

Shanghai Pharmaceuticals Volatility Alert

Shanghai Pharmaceuticals Holding shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Shanghai Pharmaceuticals' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Shanghai Pharmaceuticals' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Shanghai Pharmaceuticals Fundamentals Vs Peers

Comparing Shanghai Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Shanghai Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Shanghai Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Shanghai Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Shanghai Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Shanghai Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Shanghai Pharmaceuticals to competition
FundamentalsShanghai PharmaceuticalsPeer Average
Return On Equity0.1-0.31
Return On Asset0.0281-0.14
Profit Margin0.02 %(1.27) %
Operating Margin0.04 %(5.51) %
Current Valuation9.42 B16.62 B
Shares Outstanding739.51 M571.82 M
Price To Earning5.42 X28.72 X
Price To Book0.69 X9.51 X
Price To Sales0.04 X11.42 X
Revenue215.82 B9.43 B
Gross Profit28.41 B27.38 B
EBITDA10.73 B3.9 B
Net Income5.09 B570.98 M
Cash And Equivalents37.3 B2.7 B
Cash Per Share50.45 X5.01 X
Total Debt7.16 B5.32 B
Debt To Equity0.60 %48.70 %
Current Ratio1.40 X2.16 X
Book Value Per Share89.51 X1.93 K
Cash Flow From Operations5.06 B971.22 M
Earnings Per Share1.22 X3.12 X
Price To Earnings To Growth2.52 X4.89 X
Number Of Employees47.06 K18.84 K
Beta0.33-0.15
Market Capitalization9.2 B19.03 B
Total Asset163.44 B29.47 B
Retained Earnings14.62 B9.33 B
Working Capital19.59 B1.48 B
Current Asset61.39 B9.34 B
Current Liabilities41.8 B7.9 B
Z Score1.68.72
Annual Yield0.04 %
Five Year Return3.15 %

Shanghai Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Shanghai . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Shanghai Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Shanghai Pharmaceuticals Holding? Buying financial instruments such as Shanghai Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Shanghai Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipbuilding Railroad Equipment Thematic Idea Now

Shipbuilding Railroad Equipment
Shipbuilding Railroad Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Shanghai Pink Sheet Analysis

When running Shanghai Pharmaceuticals' price analysis, check to measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.